Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
Portfolio Pulse from Vuk Zdinjak
Quest Diagnostics (NYSE:DGX) reported that post-accident marijuana positivity in the general U.S. workforce reached a 25-year high of 7.3% in 2022, up 9% from 2021. The overall workforce urine drug positivity for all drugs remained at 4.6%, the highest level in two decades.
May 18, 2023 | 1:40 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics (NYSE:DGX) revealed a 25-year high in post-accident marijuana positivity in the U.S. workforce, potentially increasing demand for drug testing services.
As the leading provider of diagnostic testing services, Quest Diagnostics may experience increased demand for drug testing services due to the rise in post-accident marijuana positivity. This could lead to higher revenues and a positive short-term impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100